Status: current, Defined. Date: 31-May 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4718201000168113 | Topreloc-XL (metoprolol succinate 95 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4718211000168111 | Topreloc-XL 95 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topreloc-XL 95 mg modified release tablet | Is a | Topreloc-XL | true | Inferred relationship | Some | ||
| Topreloc-XL 95 mg modified release tablet | Is a | metoprolol succinate 95 mg modified release tablet | true | Inferred relationship | Some | ||
| Topreloc-XL 95 mg modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Topreloc-XL 95 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Topreloc-XL 95 mg modified release tablet | has intended active ingredient | metoprolol | true | Inferred relationship | Some | 1470960491 | |
| Topreloc-XL 95 mg modified release tablet | has Australian BoSS | metoprolol succinate | true | Inferred relationship | Some | 1470960491 | |
| Topreloc-XL 95 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 522046817 |
Reference Sets
Trade product unit of use reference set
FHIR